- Home
- TIMB vs ROIV Comparison
TIMB vs ROIV Comparison
Compare TIMB & ROIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TIMB
- ROIV
- Stock Information
- Founded
- TIMB 1998
- ROIV 2014
- Country
- TIMB Brazil
- ROIV United Kingdom
- Employees
- TIMB N/A
- ROIV N/A
- Industry
- TIMB Telecommunications Equipment
- ROIV Biotechnology: Pharmaceutical Preparations
- Sector
- TIMB Telecommunications
- ROIV Health Care
- Exchange
- TIMB Nasdaq
- ROIV Nasdaq
- Market Cap
- TIMB 8.0B
- ROIV 8.4B
- IPO Year
- TIMB 1998
- ROIV N/A
- Fundamental
- Price
- TIMB $17.39
- ROIV $10.79
- Analyst Decision
- TIMB Hold
- ROIV Buy
- Analyst Count
- TIMB 4
- ROIV 4
- Target Price
- TIMB $17.00
- ROIV $17.50
- AVG Volume (30 Days)
- TIMB 296.5K
- ROIV 5.9M
- Earning Date
- TIMB 05-06-2025
- ROIV 05-29-2025
- Dividend Yield
- TIMB 6.83%
- ROIV N/A
- EPS Growth
- TIMB 17.22
- ROIV N/A
- EPS
- TIMB 0.25
- ROIV N/A
- Revenue
- TIMB $4,490,458,172.00
- ROIV $122,585,000.00
- Revenue This Year
- TIMB $8.16
- ROIV N/A
- Revenue Next Year
- TIMB $4.83
- ROIV N/A
- P/E Ratio
- TIMB $14.18
- ROIV N/A
- Revenue Growth
- TIMB 6.00
- ROIV 140.04
- 52 Week Low
- TIMB $11.32
- ROIV $8.73
- 52 Week High
- TIMB $18.39
- ROIV $13.06
- Technical
- Relative Strength Index (RSI)
- TIMB 61.63
- ROIV 50.06
- Support Level
- TIMB $17.22
- ROIV $10.58
- Resistance Level
- TIMB $17.83
- ROIV $11.77
- Average True Range (ATR)
- TIMB 0.35
- ROIV 0.34
- MACD
- TIMB 0.03
- ROIV -0.07
- Stochastic Oscillator
- TIMB 72.84
- ROIV 17.65
About TIMB TIM S.A. (Each representing 5)
TIM, which is 67%-owned by Telecom Italia, is the third largest wireless carrier in Brazil, with 62 million subscribers, equal to about 24% of the market. The firm also owns 49% of I-Systems, an infrastructure partnership that is expanding its network footprint across Brazil. I-Systems can provide broadband service to about 9 million locations, equal to 10%-15% of the country. TIM leases capacity on the venture's network to serve retail broadband customers under the UltraFibra brand. TIM also resells fiber network access from other providers, including Oi's former infrastructure business V.tal. In total, TIM claims it can offer fixed broadband service to about 16 million locations.
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.